TITLE:
Breast Reconstruction: Does It Worth to Start If the Patient Is Not Sure to Take All the Process Along?
AUTHORS:
Jesús Ricardo García-Corral, José Martínez-Lopez, Rodrigo Davila-Diaz, Blanca Arambula-Sanchez, Marco Cuervo-Vergara, Fernando Barbosa-Villarreal, Daniel De Luna, Ana Priscila Campollo Lopez, Fernando Isaac Recio Espana, Alfredo Chama Naranjo, Jaime García, Alejandro Costa, David Flores-Soto, Selina Marioni-Manriquez, Patricia Lopez-Medellin, Erika Barlandas-Quintana, Edgar Guillen-Martinez, Steve Rodriguez-Alanis, Cuahutemoc Marquez
KEYWORDS:
BREAST-Q, Breast Reconstruction, Satisfaction Index, Quality of Life, Breast Cancer, Patient’s Decision Making
JOURNAL NAME:
Journal of Biosciences and Medicines,
Vol.10 No.8,
August
23,
2022
ABSTRACT: Introduction: Breast cancer is the most common cancer in women worldwide, representing a major public health problem. There is still little information comparing the satisfaction of the patients who finished their process against the ones who start it but did not finish it. The aim of our retrospective study was to analyze the results in terms of satisfaction after one year of undergoing to complete breast reconstruction (CBR) vs incomplete breast reconstruction (IBR). Materials and Methods: Retrospective study of patients that underwent breast reconstruction (BR) surgery after mastectomy for breast cancer treatment. Performed at Hospital Central Sur de Alta Especialidad PEMEX in Mexico City, including patients from January 1, 2015 to January 01, 2020. Demographic baseline variables were included. BREAST-Q satisfaction questionnaires one year after the last reconstructive procedure were analyzed. Results: A total of 44 patients fulfilled the inclusion criteria. Of these 44 patients, 11 were included in the IBR group, and 33 patients in the CBR group. There were no statistically significant differences between the two groups in terms of age (IBR 56.09 vs CBR 53.06 years, p = 0.321); BMI (IBR 27.94 vs CBR 26.40, p = 0.253), time from mastectomy to first reconstructive procedure (IBR 22.8 vs CBR 31 months, p = 0.957), history of chemotherapy (IBR 27.3% vs CBR 33.3%, p = 0.709) and radiotherapy (IBR 54.5% vs CBR 42.4%, p = 0.484), additionally type of reconstruction, affected side or complication rate were not significantly different. Regarding postoperative satisfaction, only the second module of satisfaction with breasts displayed statistically significant differences, with a higher score in the CBR group (46.27 vs 52.27, p = 0.019). Other items explored didn’t show significant differences. Discussion: The data reported in this study suggest that regardless of whether the last stage of a BR is reached, the results in these settings can be very similar in terms of psychosocial well-being, sexual well-being, physical well-being regarding the chest area, with some degree of better perception of her breasts. Conclusion: This study suggests that the results in terms of satisfaction in BR after mastectomy for breast cancer are quite similar for patients who decide to take only the first reconstructive stage, compared with those that finished all the process along, this may be a valuable tool for decision making.